RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Respiratory Tract Infections Therapy Area Pipeline Report
Nov 2010 - 178 pages - $1,495
Upper Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010
Dec 2010 - 37 pages - $1,000
Respiratory Tract Infections Global Clinical Trials Review, Q4, 2010
Dec 2010 - 71 pages - $1,000
Urinary Tract Infections Therapy Area Pipeline Report
Nov 2010 - 178 pages - $1,495
Acute Upper Respiratory Infections (AURI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
May 2011 - 75 pages - $2,000
Viral Respiratory Tract Infection Global Clinical Trials Review, Q1, 2011
Jan 2011 - 33 pages - $1,000
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Nov 2010 - 160 pages - $1,495
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
May 2011 - 81 pages - $3,835
Urinary Tract Infections - Pipeline Review, Q1 2011
Feb 2011 - 39 pages - $500
Respiratory and Pulmonary Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
More Related Market Research Reports >>>

Your selection

Therapeutic target
Respiratory del
Respiratory tract infections del
Development phase
Phase III/IV del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us